Connective Tissue Diseases
Information
- Disease name
- Connective Tissue Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05516758 | Active, not recruiting | Phase 2 | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis | August 31, 2022 | January 23, 2025 |
| NCT04928586 | Active, not recruiting | Phase 4 | Immunosuppressant Combined With Pirfenidone in CTD-ILD | August 16, 2019 | June 1, 2025 |
| NCT00001330 | Completed | Study of Silicone-Associated Connective Tissue Diseases | November 1992 | October 2000 | |
| NCT02392130 | Completed | Phase 1 | A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin | March 2015 | June 2015 |
| NCT04171362 | Completed | N/A | The Effect of Connective Tissue Massage in Patients With Migraine | March 28, 2019 | December 20, 2019 |
| NCT04297371 | Completed | Early Detection of Cardiac Impairment and Prediction of RV Hypertrophy in Patients With CTD | July 2014 | November 2016 | |
| NCT03337165 | Completed | Phase 1 | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | December 2016 | August 2019 |
| NCT03494036 | Completed | N/A | Effect of Synbiotic on Immune Response, Gut Permeability and Microbiota in Patient With Connective Tissue Disease | October 1, 2017 | August 31, 2018 |
| NCT00522002 | Completed | CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study | August 2007 | June 2010 | |
| NCT03929120 | Completed | Phase 1 | Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD) | November 5, 2019 | February 2, 2022 |
| NCT00802607 | Completed | Collection of Tissue Specimens for Analysis and Establishment of Cell Cultures | December 2, 2008 | October 4, 2010 | |
| NCT01656278 | Completed | N/A | An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis | March 2012 | May 2017 |
| NCT00004357 | Completed | Phase 2 | Absorption of Corticosteroids in Children With Juvenile Dermatomyositis | September 1997 | February 2008 |
| NCT06458803 | Completed | Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease | May 6, 2013 | November 19, 2023 | |
| NCT00005675 | Completed | Phase 2 | Oral Type I Collagen for Relieving Scleroderma | April 2000 | |
| NCT04896138 | Enrolling by invitation | University of Virginia Natural History Study | August 28, 2018 | August 31, 2035 | |
| NCT03683186 | Enrolling by invitation | Phase 3 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | September 23, 2019 | September 2024 |
| NCT05998759 | Not yet recruiting | Phase 2 | Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia | October 2023 | December 2025 |
| NCT06104228 | Not yet recruiting | Phase 2 | 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) | July 1, 2024 | March 31, 2026 |
| NCT05980728 | Not yet recruiting | Connective Tissue Disease Patients With Pulmonary Hypertension | November 1, 2023 | September 1, 2030 | |
| NCT06455384 | Not yet recruiting | N/A | The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services | July 1, 2024 | July 1, 2026 |
| NCT05665556 | Recruiting | REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE) | December 15, 2022 | December 2027 | |
| NCT02682511 | Recruiting | Phase 2 | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension | January 2017 | December 2025 |
| NCT03214263 | Recruiting | Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases | May 2015 | December 2024 | |
| NCT03626688 | Recruiting | Phase 3 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | August 30, 2018 | December 2024 |
| NCT04095351 | Recruiting | Connective Tissue Diseases and Lung Manifestations | December 9, 2019 | October 1, 2034 | |
| NCT04169100 | Recruiting | Phase 4 | Novel Form of Acquired Long QT Syndrome | September 28, 2011 | September 30, 2024 |
| NCT04664478 | Recruiting | Gene First Approach to Connective Tissue Disease | April 22, 2021 | February 28, 2025 | |
| NCT04915482 | Recruiting | Phase 2/Phase 3 | TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies | June 6, 2021 | February 28, 2024 |
| NCT04918524 | Recruiting | The Clinical Features and Pregnancy Outcomes of CTD Patients | September 11, 2018 | December 31, 2026 | |
| NCT04993885 | Recruiting | Phase 2 | Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies | September 1, 2021 | September 30, 2024 |
| NCT05440240 | Recruiting | Phase 4 | Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture | January 10, 2023 | March 2030 |
| NCT05505409 | Recruiting | Phase 4 | Efficacy and Safety of Pirfenidone in CTD-ILD | June 22, 2022 | December 1, 2025 |
| NCT03446339 | Unknown status | Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE) | August 3, 2017 | December 2023 | |
| NCT02768259 | Unknown status | Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients | June 2016 | May 2017 | |
| NCT04582292 | Unknown status | Laryngeal Manifestations of Connective Tissue Diseases | November 1, 2020 | December 1, 2021 | |
| NCT04428957 | Unknown status | N/A | Telemonitoring of Treatment Effects in Connective Tissue Disease-associated Interstitial Lung Disease (TEL-CTD-ILD) | February 11, 2020 | April 2022 |
| NCT04197050 | Unknown status | Phase 4 | Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD | February 20, 2020 | November 2022 |
| NCT03688191 | Unknown status | Phase 4 | Study of Sirolimus in CTD-TP in China | September 21, 2017 | September 30, 2019 |
| NCT04702295 | Unknown status | ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE) | February 2021 | August 2023 | |
| NCT03565601 | Unknown status | Prognostic Value of Anti-Ro52 Antibodies in Connective Tissue Diseases (a-Ro52) | January 1, 2019 | September 1, 2020 | |
| NCT05065814 | Unknown status | N/A | Connective Tissue Diseases and Vitamin D Deficiency | October 1, 2020 | July 1, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003240